Ondine Biomedical Inc. OBIMF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.99% | -47.03% | -51.96% | -55.90% | -62.49% |
| Total Depreciation and Amortization | -3.09% | 0.82% | 2.30% | 1.52% | 1.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.72% | 47.35% | 11.97% | 63.68% | 245.64% |
| Change in Net Operating Assets | -1.34% | 34.46% | 96.46% | 162.94% | 322.69% |
| Cash from Operations | -46.80% | -50.59% | -51.23% | -47.30% | -43.51% |
| Capital Expenditure | -772.51% | -867.77% | -1,039.19% | -498.82% | -78.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -772.51% | -867.77% | -1,039.19% | -498.82% | -78.13% |
| Total Debt Issued | -- | -- | -- | 0.00% | -- |
| Total Debt Repaid | 66.81% | 63.68% | 60.58% | 4.70% | -117.73% |
| Issuance of Common Stock | 29.29% | 21.12% | 13.06% | 43.36% | 106.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -47.18% | -3.42% | 28.38% | 12.42% | -12.24% |
| Cash from Financing | 23.07% | 17.33% | 10.21% | 45.61% | 131.17% |
| Foreign Exchange rate Adjustments | -100.41% | -71.94% | -31.17% | 85.90% | 908.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -106.39% | -97.00% | -89.50% | 36.43% | 230.58% |